RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
This report aims to provide a comprehensive presentation of the global market for RNA-Based Therapeutics and Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA-Based Therapeutics and Vaccines. This report contains market size and forecasts of RNA-Based Therapeutics and Vaccines in global, including the following market information:
Global RNA-Based Therapeutics and Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global RNA-Based Therapeutics and Vaccines market was valued at US$ 26 million in 2022 and is projected to reach US$ 558.8 million by 2029, at a CAGR of 54.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.
We surveyed the RNA-Based Therapeutics and Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA-Based Therapeutics and Vaccines Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global RNA-Based Therapeutics and Vaccines Market Segment Percentages, by Type, 2022 (%)
RNA-Based Therapeutics
RNA-Based Vaccines
Global RNA-Based Therapeutics and Vaccines Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global RNA-Based Therapeutics and Vaccines Market Segment Percentages, by Application, 2022 (%)
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
Global RNA-Based Therapeutics and Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global RNA-Based Therapeutics and Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA-Based Therapeutics and Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies RNA-Based Therapeutics and Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA-Based Therapeutics and Vaccines, market overview.
Chapter 2: Global RNA-Based Therapeutics and Vaccines market size in revenue.
Chapter 3: Detailed analysis of RNA-Based Therapeutics and Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA-Based Therapeutics and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA-Based Therapeutics and Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA-Based Therapeutics and Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA-Based Therapeutics and Vaccines Overall Market Size
2.1 Global RNA-Based Therapeutics and Vaccines Market Size: 2022 VS 2030
2.2 Global RNA-Based Therapeutics and Vaccines Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA-Based Therapeutics and Vaccines Players in Global Market
3.2 Top Global RNA-Based Therapeutics and Vaccines Companies Ranked by Revenue
3.3 Global RNA-Based Therapeutics and Vaccines Revenue by Companies
3.4 Top 3 and Top 5 RNA-Based Therapeutics and Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNA-Based Therapeutics and Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA-Based Therapeutics and Vaccines Players in Global Market
3.6.1 List of Global Tier 1 RNA-Based Therapeutics and Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA-Based Therapeutics and Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA-Based Therapeutics and Vaccines Market Size Markets, 2022 & 2030
4.1.2 RNA-Based Therapeutics
4.1.3 RNA-Based Vaccines
4.2 By Type - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
4.2.1 By Type - Global RNA-Based Therapeutics and Vaccines Revenue, 2018-2023
4.2.2 By Type - Global RNA-Based Therapeutics and Vaccines Revenue, 2024-2030
4.2.3 By Type - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA-Based Therapeutics and Vaccines Market Size, 2022 & 2030
5.1.2 Oncology
5.1.3 Immunology
5.1.4 Ophthalmology
5.1.5 Cardiovascular Diseases
5.1.6 Infectious Diseases
5.1.7 Genetic Diseases
5.1.8 Others
5.2 By Application - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
5.2.1 By Application - Global RNA-Based Therapeutics and Vaccines Revenue, 2018-2023
5.2.2 By Application - Global RNA-Based Therapeutics and Vaccines Revenue, 2024-2030
5.2.3 By Application - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global RNA-Based Therapeutics and Vaccines Market Size, 2022 & 2030
6.2 By Region - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
6.2.1 By Region - Global RNA-Based Therapeutics and Vaccines Revenue, 2018-2023
6.2.2 By Region - Global RNA-Based Therapeutics and Vaccines Revenue, 2024-2030
6.2.3 By Region - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America RNA-Based Therapeutics and Vaccines Revenue, 2018-2030
6.3.2 US RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.3.3 Canada RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.3.4 Mexico RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe RNA-Based Therapeutics and Vaccines Revenue, 2018-2030
6.4.2 Germany RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.4.3 France RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.4.4 U.K. RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.4.5 Italy RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.4.6 Russia RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.4.7 Nordic Countries RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.4.8 Benelux RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia RNA-Based Therapeutics and Vaccines Revenue, 2018-2030
6.5.2 China RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.5.3 Japan RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.5.4 South Korea RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.5.5 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.5.6 India RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America RNA-Based Therapeutics and Vaccines Revenue, 2018-2030
6.6.2 Brazil RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.6.3 Argentina RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue, 2018-2030
6.7.2 Turkey RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.7.3 Israel RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.7.4 Saudi Arabia RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
6.7.5 UAE RNA-Based Therapeutics and Vaccines Market Size, 2018-2030
7 RNA-Based Therapeutics and Vaccines Companies Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Company Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.1.4 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.1.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.2 Arbutus Biopharma
7.2.1 Arbutus Biopharma Company Summary
7.2.2 Arbutus Biopharma Business Overview
7.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Major Product Offerings
7.2.4 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.2.5 Arbutus Biopharma Key News & Latest Developments
7.3 Arrowhead Pharmaceuticals
7.3.1 Arrowhead Pharmaceuticals Company Summary
7.3.2 Arrowhead Pharmaceuticals Business Overview
7.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.3.4 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.3.5 Arrowhead Pharmaceuticals Key News & Latest Developments
7.4 BioNTech
7.4.1 BioNTech Company Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech RNA-Based Therapeutics and Vaccines Major Product Offerings
7.4.4 BioNTech RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.4.5 BioNTech Key News & Latest Developments
7.5 CureVac
7.5.1 CureVac Company Summary
7.5.2 CureVac Business Overview
7.5.3 CureVac RNA-Based Therapeutics and Vaccines Major Product Offerings
7.5.4 CureVac RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.5.5 CureVac Key News & Latest Developments
7.6 Dicerna Pharmaceuticals
7.6.1 Dicerna Pharmaceuticals Company Summary
7.6.2 Dicerna Pharmaceuticals Business Overview
7.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.6.4 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.6.5 Dicerna Pharmaceuticals Key News & Latest Developments
7.7 Regulus Therapeutics
7.7.1 Regulus Therapeutics Company Summary
7.7.2 Regulus Therapeutics Business Overview
7.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.7.4 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.7.5 Regulus Therapeutics Key News & Latest Developments
7.8 Marina Biotech
7.8.1 Marina Biotech Company Summary
7.8.2 Marina Biotech Business Overview
7.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Major Product Offerings
7.8.4 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.8.5 Marina Biotech Key News & Latest Developments
7.9 MiRagen Therapeutics
7.9.1 MiRagen Therapeutics Company Summary
7.9.2 MiRagen Therapeutics Business Overview
7.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.9.4 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.9.5 MiRagen Therapeutics Key News & Latest Developments
7.10 Moderna Therapeutics
7.10.1 Moderna Therapeutics Company Summary
7.10.2 Moderna Therapeutics Business Overview
7.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.10.4 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.10.5 Moderna Therapeutics Key News & Latest Developments
7.11 Quark Pharmaceuticals
7.11.1 Quark Pharmaceuticals Company Summary
7.11.2 Quark Pharmaceuticals Business Overview
7.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.11.4 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.11.5 Quark Pharmaceuticals Key News & Latest Developments
7.12 Roche
7.12.1 Roche Company Summary
7.12.2 Roche Business Overview
7.12.3 Roche RNA-Based Therapeutics and Vaccines Major Product Offerings
7.12.4 Roche RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.12.5 Roche Key News & Latest Developments
7.13 Sylentis
7.13.1 Sylentis Company Summary
7.13.2 Sylentis Business Overview
7.13.3 Sylentis RNA-Based Therapeutics and Vaccines Major Product Offerings
7.13.4 Sylentis RNA-Based Therapeutics and Vaccines Revenue in Global Market (2018-2023)
7.13.5 Sylentis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. RNA-Based Therapeutics and Vaccines Market Opportunities & Trends in Global Market
Table 2. RNA-Based Therapeutics and Vaccines Market Drivers in Global Market
Table 3. RNA-Based Therapeutics and Vaccines Market Restraints in Global Market
Table 4. Key Players of RNA-Based Therapeutics and Vaccines in Global Market
Table 5. Top RNA-Based Therapeutics and Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global RNA-Based Therapeutics and Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global RNA-Based Therapeutics and Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies RNA-Based Therapeutics and Vaccines Product Type
Table 9. List of Global Tier 1 RNA-Based Therapeutics and Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA-Based Therapeutics and Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - RNA-Based Therapeutics and Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - RNA-Based Therapeutics and Vaccines Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - RNA-Based Therapeutics and Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - RNA-Based Therapeutics and Vaccines Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2024-2030
Table 30. Alnylam Pharmaceuticals Company Summary
Table 31. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offerings
Table 32. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Alnylam Pharmaceuticals Key News & Latest Developments
Table 34. Arbutus Biopharma Company Summary
Table 35. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Offerings
Table 36. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Arbutus Biopharma Key News & Latest Developments
Table 38. Arrowhead Pharmaceuticals Company Summary
Table 39. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offerings
Table 40. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Arrowhead Pharmaceuticals Key News & Latest Developments
Table 42. BioNTech Company Summary
Table 43. BioNTech RNA-Based Therapeutics and Vaccines Product Offerings
Table 44. BioNTech RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. BioNTech Key News & Latest Developments
Table 46. CureVac Company Summary
Table 47. CureVac RNA-Based Therapeutics and Vaccines Product Offerings
Table 48. CureVac RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. CureVac Key News & Latest Developments
Table 50. Dicerna Pharmaceuticals Company Summary
Table 51. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offerings
Table 52. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. Dicerna Pharmaceuticals Key News & Latest Developments
Table 54. Regulus Therapeutics Company Summary
Table 55. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Offerings
Table 56. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Regulus Therapeutics Key News & Latest Developments
Table 58. Marina Biotech Company Summary
Table 59. Marina Biotech RNA-Based Therapeutics and Vaccines Product Offerings
Table 60. Marina Biotech RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. Marina Biotech Key News & Latest Developments
Table 62. MiRagen Therapeutics Company Summary
Table 63. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Offerings
Table 64. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. MiRagen Therapeutics Key News & Latest Developments
Table 66. Moderna Therapeutics Company Summary
Table 67. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Offerings
Table 68. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 69. Moderna Therapeutics Key News & Latest Developments
Table 70. Quark Pharmaceuticals Company Summary
Table 71. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offerings
Table 72. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 73. Quark Pharmaceuticals Key News & Latest Developments
Table 74. Roche Company Summary
Table 75. Roche RNA-Based Therapeutics and Vaccines Product Offerings
Table 76. Roche RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 77. Roche Key News & Latest Developments
Table 78. Sylentis Company Summary
Table 79. Sylentis RNA-Based Therapeutics and Vaccines Product Offerings
Table 80. Sylentis RNA-Based Therapeutics and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 81. Sylentis Key News & Latest Developments
List of Figures
Figure 1. RNA-Based Therapeutics and Vaccines Segment by Type in 2022
Figure 2. RNA-Based Therapeutics and Vaccines Segment by Application in 2022
Figure 3. Global RNA-Based Therapeutics and Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global RNA-Based Therapeutics and Vaccines Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global RNA-Based Therapeutics and Vaccines Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNA-Based Therapeutics and Vaccines Revenue in 2022
Figure 8. By Type - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 9. By Application - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 10. By Type - Global RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 12. By Application - Global RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 14. By Region - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 15. By Country - North America RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 16. US RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 17. Canada RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 20. Germany RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 21. France RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 23. Italy RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 24. Russia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 28. China RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 29. Japan RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 32. India RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 34. Brazil RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue Market Share, 2018-2030
Figure 37. Turkey RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 38. Israel RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 40. UAE RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2018-2030
Figure 41. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BioNTech RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. CureVac RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Marina Biotech RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Roche RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sylentis RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
